• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用绝对中性粒细胞计数阈值作为骨髓充分恢复的替代标志物,评估癌症合并发热性中性粒细胞减少症患儿停用抗生素后出院的安全性。

Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.

机构信息

Department of Pediatrics, Vanderbilt University School of Medicine and the Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.

Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.

出版信息

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26875. Epub 2017 Nov 8.

DOI:10.1002/pbc.26875
PMID:29115709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6628262/
Abstract

BACKGROUND

Febrile neutropenia (F&N) is common among pediatric oncology patients. However, there is a lack of clarity regarding parameters whereby such patients have demonstrated adequate bone marrow recovery for hospital discharge and empiric antibiotic discontinuation.

PROCEDURE

A retrospective review was performed for 350 episodes of F&N occurring at a single institution between 2007 and 2012 in pediatric oncology patients who were afebrile for 24 hr and had no bacterial source identified. Seven-day postdischarge outcomes were assessed and compared based on absolute neutrophil count (ANC) at discharge in order to identify an optimal threshold.

RESULTS

Overall, 7-day readmission rates were low (17/350, 4.6%), with patients discharged with post-nadir ANC of 100-199/μl (2/51, 3.9%), 200-499/μl (5/125, 4.0%), and ≥500/μl (8/160, 5.0%), all having similar rates. Patients with a discharge ANC < 100/μl (2/14, 14.3%) had a higher readmission rate. A new bloodstream infection was identified upon readmission in one patient in each discharge ANC range except for ANC of 100-199/μl, in which none occurred. In a subset of 217 episodes where the ANC fell below 200/μl during the admission and subsequently rose above 100/μl, 94 episodes resulted in 126 additional hospital days while subjects awaited further count recovery. One death occurred in a patient whose ANC at discharge was 290/μl. This patient had received additional chemotherapy after count recovery and prior to discharge, and was readmitted with Clostridium tertium bacteremia.

CONCLUSION

These results suggest that a post-nadir ANC > 100/μl is a safe threshold value for empiric antibiotic discontinuation and discharge home.

摘要

背景

发热性中性粒细胞减少症(F&N)在儿科肿瘤患者中很常见。然而,对于此类患者骨髓恢复足以出院和停用经验性抗生素的参数尚不清楚。

方法

对 2007 年至 2012 年在单一机构发生的 350 例儿科肿瘤患者 F&N 发作进行回顾性分析,这些患者发热 24 小时后体温正常且未发现细菌来源。根据出院时的绝对中性粒细胞计数(ANC)评估并比较 7 天出院后结局,以确定最佳阈值。

结果

总体而言,7 天再入院率较低(17/350,4.6%),出院时 ANC 后最低值为 100-199/μl(51 例中有 2 例,3.9%)、200-499/μl(125 例中有 5 例,4.0%)和≥500/μl(160 例中有 8 例,5.0%)的患者再入院率相似。ANC<100/μl(14 例中有 2 例,14.3%)的患者再入院率较高。除 ANC 为 100-199/μl 的患者外,每位出院 ANC 范围内的患者在再次入院时均发现新的血流感染。在 ANC 降至 200/μl 以下且随后升至 100/μl 以上的 217 例亚组中,94 例导致 126 例患者需额外住院治疗,等待进一步计数恢复。一名 ANC 出院时为 290/μl 的患者死亡。该患者在计数恢复后并在出院前接受了额外的化疗,并因梭状芽孢杆菌感染入院。

结论

这些结果表明,ANC 后最低值>100/μl 是停用经验性抗生素和出院回家的安全阈值。

相似文献

1
Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.使用绝对中性粒细胞计数阈值作为骨髓充分恢复的替代标志物,评估癌症合并发热性中性粒细胞减少症患儿停用抗生素后出院的安全性。
Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26875. Epub 2017 Nov 8.
2
Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.绝对单核细胞计数作为儿科肿瘤患者无病因发热性中性粒细胞减少症中早期、安全的抗生素停药标志物。
J Pediatr Hematol Oncol. 2023 Aug 1;45(6):e702-e709. doi: 10.1097/MPH.0000000000002696. Epub 2023 Jun 26.
3
Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.低风险癌症患儿因发热和中性粒细胞减少症入院后早期出院的安全性和成本效益
Cancer. 1994 Jul 1;74(1):189-96. doi: 10.1002/1097-0142(19940701)74:1<189::aid-cncr2820740130>3.0.co;2-7.
4
Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia.部分患有癌症且中性粒细胞减少持续时间较长的发热儿童及青少年早期出院的安全性
Med Pediatr Oncol. 1997 Mar;28(3):191-5. doi: 10.1002/(sici)1096-911x(199703)28:3<191::aid-mpo7>3.0.co;2-e.
5
Outcomes of Children Discharged Prior to Absolute Neutrophil Count Recovery After Admission for Febrile Neutropenia.发热性中性粒细胞减少症入院后绝对中性粒细胞计数恢复前出院患儿的结局。
J Pediatr Hematol Oncol. 2023 Nov 1;45(8):e948-e952. doi: 10.1097/MPH.0000000000002757. Epub 2023 Sep 13.
6
Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.因发热住院的中性粒细胞减少患者骨髓恢复的血液学预测指标:对停用抗生素及早期出院的意义
J Pediatr. 1992 Jul;121(1):28-33. doi: 10.1016/s0022-3476(05)82536-3.
7
Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia. A preliminary prospective trial.对于发热性中性粒细胞减少症患儿,无论中性粒细胞绝对值如何,停用抗生素都是安全的。一项初步前瞻性试验。
J Pediatr Hematol Oncol. 1995 Nov;17(4):325-30. doi: 10.1097/00043426-199511000-00008.
8
Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia.评估因发热性中性粒细胞减少症而住院的儿科肿瘤患者的安全出院标准。
J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e880-e885. doi: 10.1097/MPH.0000000000002074.
9
Early discharge of low-risk febrile neutropenic children and adolescents with cancer.癌症低风险发热性中性粒细胞减少儿童及青少年的早期出院
Clin Infect Dis. 1997 Jul;25(1):74-8. doi: 10.1086/514512.
10
Short courses of intravenous empirical antibiotic treatment in selected febrile neutropenic children with cancer.对部分发热性中性粒细胞减少的癌症患儿进行短期静脉经验性抗生素治疗。
Infection. 2002 Jan;30(1):17-21. doi: 10.1007/s15010-002-2094-1.

引用本文的文献

1
Recent advances in the prevention and management of infections in children undergoing treatment for cancer.癌症治疗中儿童感染预防与管理的最新进展。
F1000Res. 2019 Nov 12;8. doi: 10.12688/f1000research.19337.1. eCollection 2019.

本文引用的文献

1
Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.因发热入院的中性粒细胞减少的儿科肿瘤患者的早期出院
Pediatr Blood Cancer. 2016 Oct;63(10):1829-33. doi: 10.1002/pbc.26072. Epub 2016 May 19.
2
Variation in Management of Fever and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in Michigan.密歇根州癌症患儿发热和中性粒细胞减少症管理的差异:对医疗服务提供者的一项调查
Pediatr Hematol Oncol. 2015;32(5):331-40. doi: 10.3109/08880018.2015.1036331. Epub 2015 Jun 18.
3
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation.儿童癌症患者和/或接受造血干细胞移植后发热与中性粒细胞减少的管理指南。
J Clin Oncol. 2012 Dec 10;30(35):4427-38. doi: 10.1200/JCO.2012.42.7161. Epub 2012 Sep 17.
4
A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia.儿童发热伴中性粒细胞减少症患者使用抗假单胞青霉素和头孢菌素的荟萃分析。
Pediatr Infect Dis J. 2012 Apr;31(4):353-8. doi: 10.1097/INF.0b013e318242590e.
5
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.抗菌药物在肿瘤中性粒细胞减少患者中应用的临床实践指南:美国传染病学会 2010 年更新版。
Clin Infect Dis. 2011 Feb 15;52(4):427-31. doi: 10.1093/cid/ciq147. Epub 2011 Jan 4.
6
Risk determinants for catheter-associated blood stream infections in children and young adults with cancer.癌症患儿及年轻成人导管相关血流感染的风险决定因素
Pediatr Blood Cancer. 2008 Jul;51(1):53-8. doi: 10.1002/pbc.21497.
7
A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.一种用于预测化疗引起的发热性中性粒细胞减少症患儿严重感染并发症的评分方案。
J Pediatr Hematol Oncol. 2006 Oct;28(10):665-70. doi: 10.1097/01.mph.0000212996.94929.0b.
8
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.儿童肿瘤发热性中性粒细胞减少症患者静脉抗菌治疗的早期停用
BMC Pediatr. 2005 May 18;5(1):10. doi: 10.1186/1471-2431-5-10.
9
Hematological changes and predictors of bone marrow recovery in patients with neutropenic episodes in acute lymphoblastic leukemia.急性淋巴细胞白血病中性粒细胞减少症患者的血液学变化及骨髓恢复的预测因素
J Trop Pediatr. 2002 Aug;48(4):200-3. doi: 10.1093/tropej/48.4.200.
10
Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.单药治疗或含氨基糖苷类药物的联合治疗用于发热性中性粒细胞减少患者的经验性抗生素治疗:一项荟萃分析。
Lancet Infect Dis. 2002 Apr;2(4):231-42. doi: 10.1016/s1473-3099(02)00241-4.